Insider Sell Tyra Biosciences Inc COO Daniel Bensen Sells 9,152 Shares

TYRA Stock  USD 15.68  0.32  2.00%   
About 56% of Tyra Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Tyra Biosciences suggests that many traders are alarmed. The current market sentiment, together with Tyra Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Tyra Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Tyra Biosciences Inc , a company focused on developing precision medicine for patients with cancer, has reported an insider sell according to a recent SEC filing.

Read at finance.yahoo.com
Yahoo News
  

Tyra Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Tyra Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tyra Biosciences Fundamental Analysis

We analyze Tyra Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tyra Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tyra Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Tyra Biosciences is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Tyra Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tyra Biosciences stock to make a market-neutral strategy. Peer analysis of Tyra Biosciences could also be used in its relative valuation, which is a method of valuing Tyra Biosciences by comparing valuation metrics with similar companies.

Peers

Tyra Biosciences Related Equities

GLUEMonte Rosa   13.72   
0%
100.0%
CCCCC4 Therapeutics   8.59   
0%
62.0%
XLOXilio Development   7.92   
0%
57.0%
IPSCCentury Therapeutics   5.52   
0%
40.0%
CNTBConnect Biopharma   2.91   
0%
21.0%
CGEMCullinan Oncology   2.75   
0%
20.0%
EWTXEdgewise Therapeutics   2.48   
0%
18.0%
RAPTRAPT Therapeutics   2.44   
0%
17.0%
IKNAIkena Oncology   2.37   
0%
17.0%
STOKStoke Therapeutics   1.68   
0%
12.0%
HOWLWerewolf Therapeutics   1.52   
0%
11.0%
PMVPPmv Pharmaceuticals   1.25   
0%
9.0%
DSGNDesign Therapeutics   0.50   
0%
3.0%
MOLNMolecular Partners   0.17   
1.0%
0%
ERASErasca   2.05   
14.0%
0%
PHVSPharvaris   2.06   
15.0%
0%
MLYSMineralys Therapeutics,   2.59   
18.0%
0%

Complementary Tools for Tyra Stock analysis

When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges